Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Maha A. Behairy"'
Autor:
Maha A. Behairy, Reem M. Elsharabasy, Abdel Bassit El Shaarawy, Walid Anwar, Zeinab Ahmed Mahmoud, Lina Essam Khedr
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 1, Pp e7-e7 (2022)
Introduction: Low 25-hydroxyvitamin D (25(OH)D) level in hemodialysis (HD) patients is associated with high bone turnover, secondary hyperparathyroidism, and decreased bone mineral density (BMD). Objective: To investigate the efficacy of equivalent d
Externí odkaz:
https://doaj.org/article/7bb597d410ea477b822ee4f5314e6524
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 1, Pp e5-e5 (2022)
Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients. Objective
Externí odkaz:
https://doaj.org/article/8a4ebf413edf4aa9a895d6a4a4301004
Publikováno v:
Journal of Nephropharmacology, Vol 9, Iss 1, Pp e03-e03 (2020)
Introduction: Intravenous (IV) iron which is a potent pro-oxidant may decrease the phagocytic function of neutrophils and subsequently leads to repeated bacterial infections in patients on chronic regular hemodialysis (HD).Objectives: We aimed to eva
Externí odkaz:
https://doaj.org/article/5e5f327db1554002b3c50cdd1fc32933
Autor:
Maha Abdelmoneim Behairy, Marwa Mosaad Shakweer, Tamer Wahid El Said, Nermin Hassan ElGharbawy
Publikováno v:
Nefrología, Vol 38, Iss 1, Pp 64-72 (2018)
Podocalyxin is an electronegative sialoglycoprotein that prevents the podocyte foot process from collapsing. The aim of this study was to detect an association between the glomerular immunohistochemical (IHC) expression of podocalyxin and the degree
Externí odkaz:
https://doaj.org/article/af15305fc8ee4c5db159a8454881c39f
Autor:
Abdelbassit ElShaarawy, Maha Abdelmoneim Behairy, Somia Abdelhameed Bawady, Hoda Ahmed Abdelsattar, Eman Shadad
Publikováno v:
Journal of Nephropathology, Vol 8, Iss 3, Pp e26-e26 (2019)
Background: Albuminuria showed to be a deteriorating condition in diabetic kidney disease (DKD) associated with high morbidity and mortality. A need for a novel marker for early detection of DKD development and progression becomes mandating. Objectiv
Externí odkaz:
https://doaj.org/article/d5f38d49078845f98f182888a16ff6e2
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 34:75-85
Chronic hemodialysis (HD) patients are among the highest population risk for accelerated atherosclerosis. Osteopontin (OPN) is a multifunctional protein that is increased in chronic kidney disease that may play a role in vascular remodelling and inti
Publikováno v:
Journal of Nephropathology.
Introduction: Podocyturia can be considered as a noninvasive marker for evaluation and follow up of glomerular disease progression. Objectives: In this study, we aimed to assess the clinical utility of urinary podocin as an index of lupus nephritis a
Autor:
Gamal Mady, Waleed Anwar, Abdelrahman Ali Elbraky, Hazem Khorshid, Maha Abdelmoneim Behairy Said, Tamer Wahid El Said
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Pulmonary hypertension (PH) is not an uncommon progressive condition in prevalent hemodialysis (HD) patients, associated with high morbidity and mortality. Sildenafil drug has limited studies about the efficacy of the drug and opt
Autor:
Reem Elsharabasy, Abdelbassit Shaarawy, Waleed Anwar, Lina Khedr, Zinab Mahmoud, Maha Abdelmoneim Behairy Said
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Low 25-hydroxyvitamin D (25(OH)D) level is common in patients with chronic kidney disease and hemodialysis (HD) patients . It has been associated with high bone turnover, secondary hyperparathyroidism (SHPT), and decreased bone mi
Autor:
Heba W, El Said, Khaled H, Abou Seif, Yasser S, Ahmed, Hesham A, Abou Elleil, Tamer W, El Said, Maha A, Behairy, Mohamed M, Mohamed, Fatma A, Ahmed
Publikováno v:
Nephrology (Carlton, Vic.). 23(4)
Iron overload is frequently reported in haemodialysis (HD) patients particularly those with chronic hepatitis C virus (HCV) infection. Soluble haemojuvelin (sHJV) has recently emerged as one of the significant regulators of iron homeostasis and hepci